Recognition and Management of Adolescents with Substance Use Disorders: An Update on Evidence-Based Strategies

Healthcare providers in the United States are well positioned to recognize substance use in their patients. Providers are also key in taking steps to address issues of substance use before it escalates to abuse. Unfortunately, substance use and abuse in adolescents remains undertreated in the United States. Early intervention in adolescents with substance use/abuse disorders is crucial in averting economic cost in this population group.

This presentation will review treatment options for adolescents who present with various types of substance use disorders. Motivators for seeking treatment as well as gender and ethnicity will also be addressed. Barriers to treatment will also be discussed.

 *Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.

Credits: 1.50 Contact Hours; 1.50 are Pharmacology
Expiration Date: June 30, 2025

$40

LEARNING OBJECTIVES

After taking part in this educational activity, participants should be better able to:

-Identify the prevalence of substance use disorders among adolescents
-Describe the substances common abused by adolescents and the impact of these substances: Adolescent Growth, Development and Brain Functioning
-Describe diagnostic tools commonly used when caring for adolescents who present with substance use disorders

CE INFORMATION

Obtain Your Credits

To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificate' -> 'Transcript/Certificates Earned'  for future access.

Designation Statement

NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.

DISCLOSURES

Faculty

Contributing faculty, Charrita Ernewein, PhD, DNP, APRN, FNP-C, SANE-A, FAANP has disclosed no relevant financial relationship. 

Planners

All planners and contributors involved in this educational activity have disclosed no relevant financial relationships. 

Disclaimer

The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.

Disclosure of Unlabeled Use

This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Commercial Support

There is no commercial support for this activity.